CVE-2020-14073

Public Exploit

Description

XSS exists in PRTG Network Monitor 20.1.56.1574 via crafted map properties. An attacker with Read/Write privileges can create a map, and then use the Map Designer Properties screen to insert JavaScript code. This can be exploited against any user with View Maps or Edit Maps access.

Category

5.4
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.63%
Vendor Advisory paessler.com Vendor Advisory paessler.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://www.paessler.com/prtg/history/stable release notes vendor advisory
https://gist.github.com/alert3/e058baa33c31695f4168a1dbf77103df third party advisory exploit
https://kb.paessler.com/en/topic/88223-what-s-the-open-vulnerability-report-cve-2020-14073-that-my-security-tracker-informed-me-about vendor advisory
http://packetstormsecurity.com/files/160312/PRTG-Network-Monitor-20.4.63.1412-Cross-Site-Scripting.html exploit vdb entry third party advisory

Frequently Asked Questions

What is the severity of CVE-2020-14073?
CVE-2020-14073 has been scored as a medium severity vulnerability.
How to fix CVE-2020-14073?
To fix CVE-2020-14073, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2020-14073 being actively exploited in the wild?
It is possible that CVE-2020-14073 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.